𝛼SK or Search

ENTITY

Jiangsu Recbio Technology (2179 HK)

16

Analysis

Industrials • China

Jiangsu Recbio Technology is an innovative vaccine company dedicated to the research, development, production, and commercialization of recombinant protein vaccines and related adjuvant technologies. Its pipeline includes vaccines for cervical cancer, shingles, COVID-19, influenza, and tuberculosis. The company was founded in 2012 and is headquartered in Taizhou, Jiangsu, PRC.

more

Refresh

Exchange Announcement • 23 Sep 2026 16:32

2026 Interim Report

Exchange Announcement • 25 Aug 2026 17:12

List Of Directors And Their Roles And Functions

Exchange Announcement • 25 Aug 2026 17:08

Resignation Of Director, Secretary Of The Board, Authorised Representative And Joint Company Secretary And Appointment Of Authorised Representative

Exchange Announcement • 19 Aug 2026 22:11

List Of Directors And Their Roles And Functions

Exchange Announcement • 19 Aug 2026 22:04

Unaudited Interim Results Announcement For The Six Months Ended June 30, 2026 And Adjustment To The Composition Of The Audit Committee

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x